Truth In Advertising - Logo
Report an Ad
June 2020: A federal court judge granted final approval of the settlement agreement. December 2019: A federal judge preliminarily approved the settlement agreement. A final fairness hearing is scheduled for…
NAD inquiry finds supporting evidence lacking.
A new in-depth report by ProPublica and This American Life is questioning Tylenol’s safety and labeling.
Allegations: Misleadingly marketing that Tylenol rapid release products work faster than other products when they don’t
Allegations: Marketing products as safe without disclosing that they contain a harmful heavy metal
April 2015: This action was dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.. The reasons for the dismissal have not been…
Allegations: Misleadingly marketing medicines as “non-drowsy” when an ingredient in them causes drowsiness
Lawsuits claim infant-specific products aren’t any different than acetaminophen medications for older children.
Self-regulatory body finds ‘clean’ medicine company playing dirty.
Allegations: Falsely marketing products as “fast-release” when they do not work faster than other products marketed as “fast-release”
September 2019: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. November 2018: A class-action lawsuit was filed against Rite Aid for allegedly misleadingly…
April 2019: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. November 2018: A class-action lawsuit was filed against Walmart for allegedly misleadingly marketing…
These claims are tough to swallow.
Be careful, deceptive marketers — Santa was watching.
Deceptive health and income claims, including some tied to COVID-19, persist in wake of warning from the feds.
Civil penalties follow a 2022 TINA.org investigation and complaint to the FTC.